Luke Foster
Research Subjects
Luke Foster has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Andrew James Lemin
Department of Histocompatibility and Immunogenetics NHS Blood and Transplant Birmingham UK
1 shared publication Arash Akbarzad‐Yousefi
National Blood Service Newcastle‐upon‐Tyne Newcastle upon Tyne UK
1 shared publication- Arthi Anand
Histocompatibility and Immunogenetics Laboratory, Northwest London Pathology NHS Trust, Hammersmith Hospital, London, United Kingdom
1 shared publication - Carla Rosser
National Blood Service Tooting London UK
1 shared publication - Catherine Hastie
Gartnavel General Hospital Glasgow UK
1 shared publication - Claire Collins
Birmingham Blood Donor Centre Birmingham UK
1 shared publication
Latest Publications
- 2 November 2023
- Published by Wiley in International Journal of Immunogenetics
- Vol. 50 (S2) , 3-63
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation
Solid organ transplantation represents the best (and in many cases only) treatment option for patients with end‐stage organ failure. The effectiveness and functioning life of these transplants has improved each decade due to surgical and clinical advances, and accurate histocompatibility assessment. Patient exposure to alloantigen from another individual is a common occurrence and takes place through pregnancies, blood transfusions or previous transplantation. Such exposure to alloantigen's can lead to the formation of circulating alloreactive antibodies which can be deleterious to solid organ transplant outcome. The purpose of these guidelines is to update to the previous BSHI/BTS guidelines 2016 on the relevance, assessment, and management of alloantibodies within solid organ transplantation.
- 2 November 2023
- Published by Wiley in International Journal of Immunogenetics
- Vol. 50 (S2) , 3-63
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation
Solid organ transplantation represents the best (and in many cases only) treatment option for patients with end‐stage organ failure. The effectiveness and functioning life of these transplants has improved each decade due to surgical and clinical advances, and accurate histocompatibility assessment. Patient exposure to alloantigen from another individual is a common occurrence and takes place through pregnancies, blood transfusions or previous transplantation. Such exposure to alloantigen's can lead to the formation of circulating alloreactive antibodies which can be deleterious to solid organ transplant outcome. The purpose of these guidelines is to update to the previous BSHI/BTS guidelines 2016 on the relevance, assessment, and management of alloantibodies within solid organ transplantation.
HLA‐DPB1 allele frequencies in the West Midlands region of the United Kingdom: A critical evaluation against the common, intermediate and well‐documented allele catalogues CWD 2.0.0, EFI CWD and CIWD 3.0.0
The Birmingham H&I laboratory performed HLA typing on 456 potential deceased solid organ donors in the UK between 2014‐2016. Accurate DPB1 typing is essential for determining HLA compatibility in transplantation, thus we report HLA‐DPB1 for potential deceased solid organ donors. To correctly interpret HLA typing data, laboratories must understand both international and local HLA allele frequencies. In this analysis we determined HLA‐DPB1 allele and phenotype frequencies for these 456 donors. HLA‐DPB1 diversity was evaluated against the common and well‐documented (CWD) alleles 2.0.0 catalogue, the European Federation for Immunogenetics (EFI) CWD catalogue and the common, intermediate and well‐documented (CIWD) 3.0.0 catalogue. Additionally, we determined which alleles are common in our local deceased donor population. We observed 27 HLA‐DPB1 alleles with DPB1*04:01 being the most frequently observed (allele frequency=0.4342). All alleles detected locally were present in CIWD 3.0.0 however DPB1*124:01 and *135:01 were not present in CWD 2.0.0 and DPB1*104:01 and *135:01 were not present in the EFI CWD. Twenty of 27 DPB1 alleles identified were defined as locally common and also listed as common in CIWD 3.0.0 representing 62.5% of common alleles in the subset of CIWD 3.0.0 from individuals of a European geographic, ancestral or ethnic background. The alleles HLA‐DPB1*16:01 and *20:01 are locally common but not listed as common in the EFI CWD and DPB1*104:01 is not listed as common in CWD 2.0.0 catalogue. Our analysis showed that the detected alleles and locally common alleles within our population were aligned with CIWD 3.0.0 catalogue.
HLA‐DPB1 allele frequencies in the West Midlands region of the United Kingdom: A critical evaluation against the common, intermediate and well‐documented allele catalogues CWD 2.0.0, EFI CWD and CIWD 3.0.0
The Birmingham H&I laboratory performed HLA typing on 456 potential deceased solid organ donors in the UK between 2014‐2016. Accurate DPB1 typing is essential for determining HLA compatibility in transplantation, thus we report HLA‐DPB1 for potential deceased solid organ donors. To correctly interpret HLA typing data, laboratories must understand both international and local HLA allele frequencies. In this analysis we determined HLA‐DPB1 allele and phenotype frequencies for these 456 donors. HLA‐DPB1 diversity was evaluated against the common and well‐documented (CWD) alleles 2.0.0 catalogue, the European Federation for Immunogenetics (EFI) CWD catalogue and the common, intermediate and well‐documented (CIWD) 3.0.0 catalogue. Additionally, we determined which alleles are common in our local deceased donor population. We observed 27 HLA‐DPB1 alleles with DPB1*04:01 being the most frequently observed (allele frequency=0.4342). All alleles detected locally were present in CIWD 3.0.0 however DPB1*124:01 and *135:01 were not present in CWD 2.0.0 and DPB1*104:01 and *135:01 were not present in the EFI CWD. Twenty of 27 DPB1 alleles identified were defined as locally common and also listed as common in CIWD 3.0.0 representing 62.5% of common alleles in the subset of CIWD 3.0.0 from individuals of a European geographic, ancestral or ethnic background. The alleles HLA‐DPB1*16:01 and *20:01 are locally common but not listed as common in the EFI CWD and DPB1*104:01 is not listed as common in CWD 2.0.0 catalogue. Our analysis showed that the detected alleles and locally common alleles within our population were aligned with CIWD 3.0.0 catalogue.